Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Vaccines Market Opportunities And Strategies To 2032

Vaccines Market 2023 – By Type (Anti-Infective Vaccines, Anti-Cancer Vaccines, Other Type), By Technology (Conjugate Vaccines, Inactivated And Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Other Technologies), By Route Of Administration (Intramuscular (IM), Subcutaneous (SC), Oral, Other Route of Administration), By Valance (Monovalent, Multivalent), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales), And By Region, Opportunities And Strategies – Global Forecast To 2032

Vaccines Global Market Opportunities And Strategies To 2031

Starting Price : $5000.00 $3500.00 | Pages : 343 | Published : January 2023 | | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying
Vaccines Global Market Opportunities And Strategies To 2032

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Vaccines Market Definition

The vaccines market consists of sales of vaccines by entities (organizations, sole traders and partnerships) that produce vaccines to prevent various diseases. Vaccines are biological preparations that stimulate the immune system and prepare it to fight future infections. The vaccine triggers the production of antibodies and a cellular immune response against the pathogen or its foreign proteins.  Vaccines can be administered through different routes including intramuscular (IM), subcutaneous (SC), oral, and other routes.  Vaccine doses are administered to both children (pediatric vaccines) and adults, based on the schedule set for each vaccine. For adults, the vaccines are recommended based on age, health condition, prior vaccinations, and other factors such as occupation or location, which increase the likelihood of exposure to the pathogen. The vaccines market is segmented into anti-infective vaccines; anti-cancer vaccines; and other-vaccines. Only goods and services traded between entities or sold to end consumers are included.

Book your 30 minutes free consultation with our research experts

Contact Us

Vaccines Market Size

The vaccines market reached a value of nearly $92,607.6 million in 2021, having grown at a compound annual growth rate (CAGR) of 8.1% since 2016. The market is expected to grow from $92,607.6 million in 2021 to $150,931.3 million in 2026 at a rate of 10.3%. The market is then expected to grow at a CAGR of 9.0% from 2026 and reach $232,624.0 million in 2031.      

Growth in the historic period resulted from increased healthcare access, the coronavirus outbreak, continuous protection towards infectious diseases and increased awareness of immunization.

Going forward, increasing cases of invasive cervical cancer, strong late-stage pipeline and new vaccine approvals, increasing prevalence of infectious diseases among children, emergence of zoonotic diseases and vaccine resistant mutations will drive the growth. Factors that could hinder the growth of the vaccines market in the future include skilled workforce shortages and high cost of vaccines.

Vaccines Market Drivers

The key drivers of the vaccines market include:

Increasing Cases Of Invasive Cervical Cancer

Rise in cases of invasive cervical cancer is expected to propel the growth of the vaccines market during the forecast period. By using the HPV (Human papillomavirus) vaccine and regular cervical screenings, cervical cancer can be prevented. For example, according to the World Health Organization (WHO), a Switzerland based specialized agency of the United Nations responsible for international public health, the number of new cases of cervical cancer is expected to increase from 570,000 to 700,000 cases annually, between 2018 and 2030. Additionally, in 2022, according to The American Cancer Society, a US based voluntary health organization dedicated to eliminating cancer, estimates for cervical cancer in the United States, suggest about 14,100 new cases of invasive cervical cancer will be diagnosed in the year. About 4,280 women die from cervical cancer. Therefore, the increasing cases of invasive cervical cancer is expected to fuel the growth of the vaccines market during the forecast period.

Vaccines Market Restraints

The key restraints on the vaccines market include:

Skilled Workforce Shortages

Lack of suitably trained employees is expected to contribute to a shortage of labor across the professional services market for developing vaccines. Many companies are looking for candidates with advanced scientific skillsets leading to increasing competition for resources with these skillsets. This could impact the growth of the vaccine market which is heavily reliant on skilled manpower. For instance, according to a research by the National Association of Manufacturing, a US based advocacy group and Deloitte, a UK based professional services network, the number of vacancies for science, technology, engineering and math (STEM) jobs is expected to be around 3.5 million by 2025, but around 2 million of those jobs are likely to go unfilled due to shortage of people with the required skillset. Therefore, the skilled workforce shortages is likely to restrain the growth of the vaccines market during the forecast period.

Vaccines Market Trends

Major trends influencing the vaccines market include:

Synthetic Biology In Vaccine Development

Synthetic biology is being increasingly used by companies that are developing vaccines. Synthetic biology is a field of biology which involves engineering principles, whereby molecules and organisms are redesigned for useful purposes by engineering them to have new abilities. Synthetic biology tools significantly aid in drug discovery processes to help understand the molecular mechanisms of target diseases. Traditionally, vaccines are developed using the whole organism. Synthetic vaccines are based on complex carbohydrate-protein conjugates and can be easily stored at normal temperature without the need for refrigeration. Synthetic biology technologies such as DNA (Deoxyribonucleic acid) - and mRNA(Messenger Ribonucleic acid)-based vaccine technologies allow researchers to move rapidly from an organisms genomic sequence to a vaccine that directly encodes the organisms proteins, which can begin clinical trials. For example, in 2020, the US National Institute of Health, a US based primary agency of the responsible for biomedical and public health research, identified the importance of synthetic biology to speed up vaccine development. Additionally, in February 2020, the Bill & Melinda Gates Foundation, a US based private foundation, funded $60 million to COVID-19 research and vaccine developments based on synthetic biology.

Development Of Combination Vaccines

There has been an increasing demand for combination vaccines among infants and children. The development of combination vaccines for protection against multiple diseases was initiated by combining separate vaccines against tetanus, diphtheria, and pertussis into a single dose. The combination vaccines simplify childhood immunization schedules and reduce the number of injections while protecting against several serious diseases. Many companies have started developing combination vaccines as the demand increased. For instance, in November 2022, Pfizer Inc, a US based pharmaceutical and biotechnology corporation and BioNTech SE, a Germany based biotechnology company, announced the advancement of an mRNA-based combination vaccine candidate for influenza and COVID-19 to a Phase 1 trial with the aim to address two severe respiratory diseases with one vaccine. The first participant has been dosed in a Phase 1 trial evaluating the safety, tolerability, and immunogenicity of a nucleoside-modified RNA (Ribonucleic acid) (modRNA)-based combination vaccine approach. Further, in October 2020, Merck, a US based pharmaceutical company and Sanofi Pasteur, a France based pharmaceutical company, formed a U.S.-based joint-partnership vaccine company that developed, manufactured and marketed, VAXELIS, a combination vaccine for Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B.

Opportunities And Recommendations In The Vaccines Market

Opportunities –The top opportunities in the vaccines market segmented by type will arise in the anti-infective vaccines segment, which will gain $49,866.9 million of global annual sales by 2026. The top opportunities in segment by technology will arise in the conjugate vaccines segment, which will gain $26,610.1 million of global annual sales by 2026. The top opportunities in segment by route of administration will arise in the intramuscular (IM) segment, which will gain $30,201.7 million of global annual sales by 2026. The top opportunities in segment by valence will arise in the multivalent segment, which will gain $38,172.2 million of global annual sales by 2026. The top opportunities in segment by distribution channel will arise in the hospital pharmacies segment, which will gain $37,872.6 million of global annual sales by 2026. The vaccines market size will gain the most in the USA at $27,549.2 million.    

Recommendations-To take advantage of the opportunities, The Business Research Company recommends the companies in the vaccines market to focus on development of combination vaccines, focus on research and development, focus on artificial intelligence, expand in emerging markets, continue to focus on developed markets, focus on partnerships and collaborations, provide competitively priced offerings, participate in trade shows and events, continue to use business-to-business (B2B) promotions and continue to target fast-growing end-users.

Vaccines Market Segmentation

The vaccines market is segmented by type, by technology, by route of administration, by valance, by distribution channel.
By Type –
The vaccines market is segmented by type into
    • a) Anti-Infective Vaccines
    • b) Anti-Cancer Vaccines
    • c) Other Types
The anti-infective vaccines market was the largest segment of the vaccines market segmented by type, accounting for 85.9% of the total in 2021. Going forward, the anti-cancer vaccines market is expected to be the fastest growing segment in the vaccines market segmented by type, at a CAGR of 10.7% during 2021-2026.
By Technology-
The vaccines market is segmented by technology into
    • a) Conjugate Vaccines
    • b) Inactivated And Subunit Vaccines
    • c) Live Attenuated Vaccines
    • d) Recombinant Vaccines
    • e) Toxoid Vaccines
    • f) Other Technologies
The conjugate vaccines market was the largest segment of the vaccines market segmented by technology accounting for 43.9% of the total in 2021. Going forward, the other technologies market is expected to be the fastest growing segment in the vaccines market segmented by technology, at a CAGR of 17.7% during 2021-2026.
By Route Of Administration-
The vaccines market is segmented by route of administration into
    • a) Intramuscular (IM)
    • b) Subcutaneous (SC)
    • c) Oral
    • d) Other Route of Administration
The intramuscular (IM) market was the largest segment of the vaccines market segmented by route of administration, accounting for 47.5% of the total in 2021. Going forward, the intramuscular (IM) market is expected to be the fastest growing segment in the vaccines market segmented by route of administration, at a CAGR of 11.0% during 2021-2026.
By Valance-
The vaccines market is segmented by valance into
    • a) Monovalent
    • b) Multivalent
    • d) Other Route of Administration
The multivalent market was the largest segment of the vaccines market segmented by valance, accounting for 61.5% of the total in 2021. Going forward, the multivalent market is expected to be the fastest growing segment in the vaccines market segmented by valance, at a CAGR of 10.8% during 2021-2026.
By Distribution Channel -
The vaccines market is segmented by distribution channel into
    • a) Hospital Pharmacies
    • b) Retail Pharmacies
    • c) Institutional Sales
The hospital pharmacies market was the largest segment of the vaccines market segmented by distribution channel, accounting for 30.5% of the total in 2021. Going forward, the institutional sales market is expected to be the fastest growing segment in the vaccines market segmented by distribution channel, at a CAGR of 12.7% during 2021-2026.
By Geography - The vaccines market is segmented by geography into
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the vaccines market, accounting for 53.7% of the total in 2021. It was followed by Asia Pacific, and then the other regions. Going forward, the fastest-growing regions in the vaccines market will be Middle East, and, South America where growth will be at CAGRs of 14.6% and 13.0% respectively. These will be followed by Asia Pacific, and, Africa where the markets are expected to grow at CAGRs of 11.6% and 10.9% respectively.

Vaccines Market Competitive Landscape

Major Competitors are:

  • Pfizer Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • AstraZeneca

    • Other Competitors Include:

  • CSL Limited
  • Serum Institute of India Pvt. Ltd.
  • Emergent BioSolutions Inc.
  • Daiichi Sankyo Company, Limited
  • Bavarian Nordic
  • Denteric Pvt Ltd
  • Hualan Biological Engineering Inc
  • Chongqing Zhifei
  • Beijing Tiantan Biological Products Co Ltd
  • BioKangtai
  • CanSino Biologics
  • Takeda Pharmaceutical Company
  • Mitsubishi Tanabe Pharma Corporation
  • Indian Immunologicals Limited
  • Panacea Biotec Ltd
  • Zydus Cadila
  • BIO-MED
  • Sinovac Biotech Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sinopharm
  • Walvax biotechnology
  • Fosun Pharma
  • Valneva SE
  • BioFabri
  • ImevaX GmbH
  • Bayer
  • BioNTech
  • Boehringer Ingelheim
  • Novartis
  • MCM Vaccine Company
  • Seqirus
  • Roche
  • Johnson & Johnson
  • Connaught Laboratories Inc
  • Wyeth-Ayerst
  • Grifols
  • Moderna Inc
  • Verity Pharmaceuticals Canada Inc
  • Medicago Inc
  • Biodextris
  • IMV Inc
  • Virica Biotech
  • Fiocruz
  • GSK Brazil
  • Merck Brazil
  • Sinergium Biotech SA
  • Ataulfo de Paiva Foundation
  • Bio-Manguinhos–Institute of Technology on Immunobiologicals
  • Butantan Institute
  • Ezequiel Dias Foundation (FUNED)
  • National Administration of Laboratories and Institutes of Health (ANLIS)
  • Arabio
  • MIGAL Galilee Research Institute
  • Hayat-Vax
  • Phaax
  • VPS Health Care
  • Biovac Institute

      • Table Of Contents

      1.Executive Summary

      2.Table Of Contents

      3.List Of Figures

      4.List Of Tables

      5.Report Structure

      6.Introduction And Market Characteristics

      6.1.General Market Definition

      6.2.Summary

      6.3.Vaccines Market Definition And Segmentations

      6.4.Market Segmentation By Type

      6.4.1.Anti-Infective Vaccines

      6.4.2.Anti-Cancer Vaccines

      6.4.3.Other Types

      6.5.Market Segmentation By Technology

      6.5.1.Conjugate Vaccines

      6.5.2.Inactivated And Subunit Vaccines

      6.5.3.Live Attenuated Vaccines

      6.5.4.Recombinant Vaccines

      6.5.5.Toxoid Vaccines

      6.5.6.Other Technologies

      6.6.Market Segmentation By Route Of Administration

      6.6.1.Intramuscular (IM)

      6.6.2.Subcutaneous (SC)

      6.6.3.Oral

      6.6.4.Other Route of Administration

      6.7.Market Segmentation By Valance

      6.7.1.Monovalent

      6.7.2.Multivalent

      6.8.Market Segmentation By Distribution Channel

      6.8.1.Hospital Pharmacies

      6.8.2.Retail Pharmacies

      6.8.3.Institutional Sales

      7.Major Market Trends

      7.1.Synthetic Biology In Vaccine Development

      7.2.Development Of Combination Vaccines

      7.3.Robust Research And Development

      7.4.Increasing Demand For Conjugate Vaccines

      7.5.Artificial Intelligence In Vaccine Development

      7.6.mRNA Vaccines

      7.7.Cancer Vaccines

      7.8.Increasing Acquisitions And Partnerships

      8.Global Market Size And Growth

      8.1.Market Size

      8.2.Historic Market Growth, 2016 – 2021, Value ($ Million)

      8.2.1.Market Drivers 2016 – 2021

      8.2.2.Market Restraints 2016 – 2021

      8.3.Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      8.3.1.Market Drivers 2021 – 2026

      8.3.2.Market Restraints 2021 – 2026

      9.Global Vaccines Market Segmentation

      9.1.Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      9.2.Global Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      9.3.Global Vaccines Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      9.4.Global Vaccines Market, Segmentation By Valence, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      9.5.Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      10.Vaccines Market, Regional and Country Analysis

      10.1.Global Vaccines Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      10.2.Global Vaccines Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.Asia-Pacific Market

      11.1.Summary

      11.2.Market Overview

      11.2.1.Region Information

      11.2.2.Market Information

      11.2.3.Background Information

      11.2.4.Government Initiatives

      11.2.5.Regulations

      11.2.6.Regulatory Bodies

      11.2.7.Major Associations

      11.2.8.Taxes Levied

      11.2.9.Corporate Tax Structure

      11.2.10.Investments

      11.2.11.Major Companies

      11.3.Asia-Pacific Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.4.Asia-Pacific Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.5.Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.6.Asia-Pacific Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.7.Asia-Pacific Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.8.Asia-Pacific Vaccines Market: Country Analysis

      11.9.China Market

      11.10.Summary

      11.11.Market Overview

      11.11.1.Country Information

      11.11.2.Market Information

      11.11.3.Background Information

      11.11.4.Government Initiatives

      11.11.5.Regulations

      11.11.6.Regulatory Bodies

      11.11.7.Major Associations

      11.11.8.Taxes Levied

      11.11.9.Corporate Tax Structure

      11.11.10.Investments

      11.11.11.Major Companies

      11.12.China Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.13.China Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.14.China Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.15.China Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.16.China Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.17.India Market

      11.18.India Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.19.India Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.20.India Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.21.India Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.22.India Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.23.Japan Market

      11.24.Japan Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.25. Japan Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.26. Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.27. Japan Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.28. Japan Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.29. Australia Market

      11.30. Australia Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.31. Australia Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.32. Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.33. Australia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.34. Australia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.35. Indonesia Market

      11.36. Indonesia Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.37. Indonesia Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.38. Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.39. Indonesia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.40. Indonesia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.41. South Korea Market

      11.42. South Korea Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.43. South Korea Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.44. South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.45. South Korea Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.46. South Korea Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12. Western Europe Market

      12.1. Summary

      12.2. Market Overview

      12.2.1. Region Information

      12.2.2. Market Information

      12.2.3. Background Information

      12.2.4. Government Initiatives

      12.2.5. Regulations

      12.2.6. Regulatory Bodies

      12.2.7. Major Associations

      12.2.8. Taxes Levied

      12.2.9. Corporate Tax Structure

      12.2.10. Investments

      12.2.11. Major Companies

      12.3. Western Europe Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      12.4. Western Europe Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      12.5. Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.6. Western Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.7. Western Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.8. Western Europe Vaccines Market: Country Analysis

      12.9. UK Market

      12.10. UK Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      12.11. UK Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      12.12. UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.13. UK Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.14. UK Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.15. Germany Market

      12.16. Germany Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      12.17. Germany Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      12.18. Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.19. Germany Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.20. Germany Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.21. France Market

      12.22. France Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      12.23. France Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      12.24. France Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.25. France Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.26. France Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13. Eastern Europe Market

      13.1. Summary

      13.2. Market Overview

      13.2.1. Region Information

      13.2.2. Market Information

      13.2.3. Background Information

      13.2.4. Government Initiatives

      13.2.5. Regulations

      13.2.6. Regulatory Bodies

      13.2.7. Major Associations

      13.2.8. Taxes Levied

      13.2.9. Corporate Tax Structure

      13.2.10. Investments

      13.2.11. Major Companies

      13.3. Eastern Europe Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.4. Eastern Europe Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.5. Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.6. Eastern Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.7. Eastern Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.8. Eastern Europe Vaccines Market: Country Analysis

      13.9. Russia Market

      13.10. Russia Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.11. Russia Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.12. Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.13. Russia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.14. Russia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14. North America Market

      14.1. Summary

      14.2. Market Overview

      14.2.1. Region Information

      14.2.2. Market Information

      14.2.3. Background Information

      14.2.4. Government Initiatives

      14.2.5. Regulations

      14.2.6. Regulatory Bodies

      14.2.7. Major Associations

      14.2.8. Taxes Levied

      14.2.9. Corporate Tax Structure

      14.2.10. Investments

      14.2.11. Major Companies

      14.3. North America Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.4. North America Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.5. North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.6. North America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.7. North America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.8. North America Vaccines Market: Country Analysis

      14.9. USA Market

      14.10. Summary

      14.11. Market Overview

      14.11.1. Country Information

      14.11.2. Market Information

      14.11.3. Background Information

      14.11.4. Government Initiatives

      14.11.5. Regulations

      14.11.6. Regulatory Bodies

      14.11.7. Major Associations

      14.11.8. Taxes Levied

      14.11.9. Corporate Tax Structure

      14.11.10. Investments

      14.11.11. Major Companies

      14.12. USA Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.13. USA Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.14. USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.15. USA Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.16. USA Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15. South America Market

      15.1. Summary

      15.2. Market Overview

      15.2.1. Region Information

      15.2.2. Market Information

      15.2.3. Background Information

      15.2.4. Government Initiatives

      15.2.5. Regulations

      15.2.6. Regulatory Bodies

      15.2.7. Major Associations

      15.2.8. Taxes Levied

      15.2.9. Corporate Tax Structure

      15.2.10. Investments

      15.2.11. Major Companies

      15.3. South America Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      15.4. South America Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      15.5. South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.6. South America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.7. South America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.8. South America Vaccines Market: Country Analysis

      15.9. Brazil Market

      15.10. Brazil Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      15.11. Brazil Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      15.12. Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.13. Brazil Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.14. Brazil Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16. Middle East Market

      16.1. Summary

      16.2. Market Overview

      16.2.1. Region Information

      16.2.2. Market Information

      16.2.3. Background Information

      16.2.4. Government Initiatives

      16.2.5. Regulations

      16.2.6. Regulatory Bodies

      16.2.7. Major Associations

      16.2.8. Taxes Levied

      16.2.9. Corporate Tax Structure

      16.2.10. Investments

      16.2.11. Major Companies

      16.3. Middle East Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      16.4. Middle East Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      16.5. Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16.6. Middle East Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16.7. Middle East Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17. Africa Market

      17.1. Summary

      17.2. Market Overview

      17.2.1. Region Information

      17.2.2. Market Information

      17.2.3. Background Information

      17.2.4. Government Initiatives

      17.2.5. Regulations

      17.2.6. Regulatory Bodies

      17.2.7. Major Associations

      17.2.8. Taxes Levied

      17.2.9. Corporate Tax Structure

      17.2.10. Investments

      17.2.11. Major Companies

      17.3. Africa Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      17.4. Africa Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      17.5. Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17.6. Africa Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17.7. Africa Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      18. Competitive Landscape and Company Profiles

      19. Company Profiles

      19.1. Pfizer Inc

      19.1.1. Company Overview

      19.1.2. Products And Services

      19.1.3. Business Strategy

      19.1.4. Financial Overview

      19.2. Merck & Co., Inc

      19.2.1. Company Overview

      19.2.2. Products And Services

      19.2.3. Business Strategy

      19.2.4. Financial Overview

      19.3. GlaxoSmithKline plc

      19.3.1. Company Overview

      19.3.2. Products And Services

      19.3.3. Business Strategy

      19.3.4. Financial Overview

      19.4. Sanofi S.A

      19.4.1. Company Overview

      19.4.2. Products And Services

      19.4.3. Business Strategy

      19.4.4. Financial Overview

      19.5. AstraZeneca plc

      19.5.1. Company Overview

      19.5.2. Products And Services

      19.5.3. Business Strategy

      19.5.4. Financial Overview

      20. Pipeline Analysis

      21. Key Mergers And Acquisitions

      21.1. GSK plc Acquired Affinivax Inc

      21.2. Ceva Santé Animale Acquired Artemis Technologies Inc.

      21.3. Pfizer Inc. Acquired ReViral Ltd.

      21.4. NEC OncoImmunity AS Acquired Vaximm AG’s Neoantigen Vaccine Development Assets.

      21.5. Sanofi S.A. To Acquire Origimm Biotechnology GmbH

      21.6. Vaccitech plc Acquired Avidea Technologies, Inc.

      21.7. Shanghai Fosun Pharmaceutical Co., Ltd. Acquired Chengdu Antejin Biotech Co. Ltd.

      21.8. Sanofi S.A. Acquired Translate Bio, Inc.

      21.9. Thermo Fisher Scientific Inc. Acquired Viral Vector Manufacturing Business from Novasep SAS

      21.10. Merck KGaA’s Life Sciences Company MilliporeSigma Acquired AmpTec

      21.11. Sanofi S.A. Acquired Kymab Ltd

      21.12. BioNTech SE Acquired GMP Certified Manufacturing Site of Novartis AG

      21.13. GlaxoSmithKline plc Acquired 10% Stake In CureVac For $163.67 million

      21.14. Merck & Co., Inc. Acquired Themis Bioscience GmbH

      21.15. Novavax, Inc. Acquired Praha Vaccines For $167 million

      21.16. Bavarian Nordic A/S Acquired Global Rights for Two Vaccines from GSK For $940.07 Million

      21.17. Bharat Biotech International Limited Acquired Chiron Behring Vaccines from GlaxoSmithKline

      22. Global Vaccines Market Opportunities And Strategies

      22.1. Global Vaccines Market In 2026 – Countries Offering Most New Opportunities

      22.2. Global Vaccines Market In 2026 – Segments Offering Most New Opportunities

      22.3. Global Vaccines Market In 2026 – Growth Strategies

      22.3.1. Market Trend Based Strategies

      22.3.2. Competitor Strategies

      23. Vaccines Market, Conclusions And Recommendations

      23.1. Conclusions

      23.2.Recommendations

      23.2.1.Product

      23.2.2.Place

      23.2.3.Price

      23.2.4.Promotion

      23.2.5.People

      24.Appendix

      24.1.Market Data Sources

      24.2.Research Methodology

      24.3.Currencies

      24.4.The Business Research Company

      24.5.Copyright and Disclaimer

    List Of Tables

      Table 1: Global Vaccines Market, Historic, 2016 – 2021, $ Million
    • Table 2: Global Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 3: Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 4: Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 5: Global Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 6: Global Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 7: Global Vaccines Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 8: Global Vaccines Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 9: Global Vaccines Market, Segmentation By Valence, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 10: Global Vaccines Market, Segmentation By Valence, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 11: Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 12: Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 13: Global Vaccines Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 14: Global Vaccines Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 15: Global Vaccines Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 16: Global Vaccines Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 17: Asia-Pacific GDP Per Capita, By Country, 2016-2021, $
    • Table 18: Asia-Pacific Population By Age Group, By Country, 2016-2026, Thousands
    • Table 19: Asia-Pacific Public Healthcare Expenditure, By Country, 2015-2020, $ Billion
    • Table 20: Asia-Pacific Private Healthcare Expenditure, By Country, 2015-2020, $ Billion
    • Table 21: Asia-Pacific Vaccines Market, Historic, 2016 – 2021, $ Million
    • Table 22: Asia-Pacific Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 23: Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 24: Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 25: Asia-Pacific Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 26: Asia-Pacific Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 27: Asia-Pacific Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 28: Asia-Pacific Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 29: China GDP Per Capita, 2016-2021, $
    • Table 30: China Population By Age Group, 2016-2026, Thousands
    • Table 31: China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 32: China Vaccines Market, Historic, 2016 – 2021, $ Million
    • Table 33: China Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 34: China Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 35: China Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 36: China Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 37: China Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 38: China Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 39: China Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 40: India Vaccines Market, Historic, 2016 – 2021, $ Million
    • Table 41: India Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 42: India Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 43: India Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 44: India Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 45: India Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 46: India Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 47: India Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 48: Japan Vaccines Market, Historic, 2016 – 2021, $ Million
    • Table 49: Japan Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 50: Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 51: Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 52: Japan Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 53: Japan Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 54: Japan Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 55: Japan Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 56: Australia Vaccines Market, Historic, 2016 – 2021, $ Million
    • Table 57: Australia Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 58: Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 59: Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 60: Australia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 61: Australia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 62: Australia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 63: Australia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 64: Indonesia Vaccines Market, Historic, 2016 – 2021, $ Million
    • Table 65: Indonesia Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 66: Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 67: Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 68: Indonesia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 69: Indonesia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 70: Indonesia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 71: Indonesia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 72: South Korea Vaccines Market, Historic, 2016 – 2021, $ Million
    • Table 73: South Korea Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 74: South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 75: South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 76: South Korea Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 77: South Korea Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 78: South Korea Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 79: South Korea Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 80: Western Europe GDP Per Capita, By Country, 2016-2021, $
    • Table 81: Western Europe Population By Age Group, By Country, 2016-2026, Thousands
    • Table 82: Western Europe Public Healthcare Expenditure, By Country, 2015-2020, $ Billion
    • Table 83: Western Europe Private Healthcare Expenditure, By Country, 2015-2020, $ Billion
    • Table 84: Western Europe Vaccines Market, Historic, 2016 – 2021, $ Million
    • Table 85: Western Europe Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 86: Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 87: Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 88: Western Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 89: Western Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 90: Western Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 91: Western Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 92: UK Vaccines Market, Historic, 2016 – 2021, $ Million
    • Table 93: UK Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 94: UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 95: UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 96: UK Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 97: UK Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 98: UK Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 99: UK Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 100: Germany Vaccines Market, Historic, 2016 – 2021, $ Million
    • Table 101: Germany Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 102: Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 103: Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 104: Germany Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 105: Germany Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 106: Germany Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 107: Germany Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 108: France Vaccines Market, Historic, 2016 – 2021, $ Million
    • Table 109: France Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 110: France Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 111: France Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 112: France Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 113: France Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 114: France Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 115: France Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 116: Eastern Europe GDP Per Capita, By Country, 2016-2021, $
    • Table 117: Eastern Europe Population By Age Group, By Country, 2016-2026, Thousands
    • Table 118: Eastern Europe Public Healthcare Expenditure, By Country, 2015-2020, $ Billion
    • Table 119:  Eastern Europe Private Healthcare Expenditure, By Country, 2015-2020, $ Billion
    • Table 120: Eastern Europe Vaccines Market, Historic, 2016 – 2021, $ Million
    • Table 121: Eastern Europe Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 122: Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 123: Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 124: Eastern Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 125: Eastern Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 126: Eastern Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 127: Eastern Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 128: Russia Vaccines Market, Historic, 2016 – 2021, $ Million
    • Table 129: Russia Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 130: Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 131: Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 132: Russia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 133: Russia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 134: Russia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 135: Russia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 136: North America GDP Per Capita, By Country, 2016-2021, $
    • Table 137: North America Population By Age Group, By Country, 2016-2026, Thousands
    • Table 138: North America Public Healthcare Expenditure, By Country, 2015-2020, $ Billion
    • Table 139: North America Private Healthcare Expenditure, By Country, 2015-2020, $ Billion
    • Table 140: North America Vaccines Market, Historic, 2016 – 2021, $ Million
    • Table 141: North America Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 142: North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 143: North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 144: North America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 145: North America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 146: North America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 147: North America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 148: USA GDP Per Capita, 2016-2021, $
    • Table 149: USA Population By Age Group, 2016-2026, Thousands
    • Table 150: USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 151: USA Vaccines Market, Historic, 2016 – 2021, $ Million
    • Table 152: USA Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 153: USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 154: USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 155: USA Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 156: USA Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 157: USA Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 158: USA Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 159: South America GDP Per Capita, By Country, 2016-2021, $
    • Table 160: South America Population By Age Group, By Country, 2016-2026, Thousands
    • Table 161: South America Public Healthcare Expenditure, By Country, 2015-2020, $ Billion
    • Table 162: South America Private Healthcare Expenditure, By Country, 2015-2020, $ Billion
    • Table 163: South America Vaccines Market, Historic, 2016 – 2021, $ Million
    • Table 164: South America Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 165: South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 166: South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 167: South America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 168: South America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 169: South America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 170: South America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 171: Brazil Vaccines Market, Historic, 2016 – 2021, $ Million
    • Table 172: Brazil Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 173: Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 174: Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 175: Brazil Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 176: Brazil Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 177: Brazil Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 178: Brazil Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 179: Middle East GDP Per Capita, By Country, 2016-2021, $
    • Table 180: Middle East Population By Age Group, By Country, 2016-2026, Thousands
    • Table 181: Middle East Public Healthcare Expenditure, By Country, 2015-2020, $ Billion
    • Table 182: Middle East Private Healthcare Expenditure, By Country, 2015-2020, $ Billion
    • Table 183: Middle East Vaccines Market, Historic, 2016 – 2021, $ Million
    • Table 184: Middle East Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 185: Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 186: Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 187: Middle East Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 188: Middle East Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 189: Middle East Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 190: Middle East Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 191: Africa GDP Per Capita, By Country, 2016-2021, $
    • Table 192: Africa Population By Age Group, By Country, 2016-2026, Thousands
    • Table 193: Africa Public Healthcare Expenditure, By Country, 2015-2020, $ Billion
    • Table 194: Africa Private Healthcare Expenditure, By Country, 2015-2020, $ Billion
    • Table 195: Africa Vaccines Market, Historic, 2016 – 2021, $ Million
    • Table 196: Africa Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 197: Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 198: Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 199: Africa Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 200: Africa Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 201: Africa Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 202: Africa Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 203: Vaccines Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
    • Table 204: Pfizer – Financial Performance, 2017– 2021, $ Billion
    • Table 205: Merck & Co – Financial Performance, 2017– 2021, $ Billion
    • Table 206: GlaxoSmithKline – Financial Performance, 2017 - 2021, $ Billion
    • Table 207: Sanofi – Financial Performance, 2017– 2021, $ Billion
    • Table 208: AstraZeneca – Financial Performance, 2017– 2021, $ Billion
    • Table 209: Global Vaccine Market, Product Pipeline Analysis
    • Table 210: Global Vaccines Market Size Gain ($ Million), 2021 – 2026, By Country
    • Table 211: Global Vaccines Market Size Gain ($ Million), Segmentation By Type, 2021 – 2026
    • Table 212: Global Vaccines Market Size Gain ($ Million), Segmentation By Technology, 2021 – 2026
    • Table 213: Global Vaccines Market Size Gain ($ Million), Segmentation By Route Of Administration, 2021 – 2026
    • Table 214: Global Vaccines Market Size Gain ($ Million), Segmentation By Valence, 2021 – 2026
    • Table 215: Global Vaccines Market Size Gain ($ Million), Segmentation By Distribution Channel, 2021 – 2026
    • Table 216: Vaccines Market Data Sources

    List Of Figures

      Figure 1: Global Vaccines Market Segmentation By Type
    • Figure 2: Global Vaccines Market Segmentation By Technology
    • Figure 3: Global Vaccines Market Segmentation By Route of Administration
    • Figure 4: Global Vaccines Market Segmentation By Valance
    • Figure 5: Global Vaccines Market Segmentation By Distribution Channel
    • Figure 6: Global Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 7: Global Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 8: Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 9: Global Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 10: Global Vaccines Market, Segmentation By Route of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 11: Global Vaccines Market, Segmentation By Valance, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 12: Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 13: Global Vaccines Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 14: Global Vaccines Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 15: Asia-Pacific Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 16: Asia-Pacific Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 17: Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 18: Asia-Pacific Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 19: China Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 20: China Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 21: China Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 22: China Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 23: India Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 24: India Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 25: India Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 26: India Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 27: Japan Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 28: Japan Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 29: Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 30: Japan Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 31: Australia Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 32: Australia Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 33: Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 34: Australia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 35: Indonesia Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 36: Indonesia Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 37: Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 38: Indonesia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 39: South Korea Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 40: South Korea Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 41: South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 42: South Korea Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 43: Western Europe Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 44: Western Europe Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 45: Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 46: Western Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 47: UK Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 48: UK Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 49: UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 50: UK Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 51: Germany Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 52: Germany Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 53: Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 54: Germany Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 55: France Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 56: France Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 57: France Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 58: France Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 59: Eastern Europe Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 60: Eastern Europe Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 61: Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 62: Eastern Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 63: Russia Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 64: Russia Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 65: Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 66: Russia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 67: North America Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 68: North America Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 69: North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 70: North America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 71: USA Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 72: USA Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 73: USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 74: USA Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 75: South America Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 76: South America Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 77: South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 78: South America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 79: Brazil Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 80: Brazil Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 81: Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 82: Brazil Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 83: Middle East Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 84: Middle East Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 85: Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 86: Middle East Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 87: Africa Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 88: Africa Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 89: Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 90: Africa Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 91: Global Vaccines Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 92: GlaxoSmithKline plc – Financial Performance, 2016 – 2020, $ Billion
    • Figure 93: Merck & Co., Inc. – Financial Performance, 2016 – 2020, $ Billion
    • Figure 94: Sanofi S.A. – Financial Performance, 2016 – 2020, $ Billion
    • Figure 95: Pfizer Inc. – Financial Performance, 2016 – 2020, $ Billion
    • Figure 96: CSL Limited – Financial Performance, 2016 – 2020, $ Billion

    The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

    Read More

    The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

    Read More

    Global Anticoagulants Market 2022 – Market Opportunities And Strategies

    Read More

    What Is The Compression Therapy Market Overview In 2022?

    Read More

    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the microbiome market research report 2022 with industry size, share, segments and market growth

    Read More

    Companion Animal Veterinary Vaccines Global Market Report 2024 – By Product (Inactivated, Live Attenuated, Recombinant, Other Products), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Drugs for Immunotherapy Global Market Report 2024 – By Type (Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors, Other Types), By Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Other Therapy Areas), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Liposomal Drug Delivery Devices Global Market Report 2024 – By Type (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, Other Types), By Application (Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy), By End User (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Cancer Vaccines Global Market Report 2024 – By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines), By Cancer Type (Prostate, Cervical, Colorectal, Throat, Other Cancer Types), By End-User (Cancer Treatment Centers, Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    DTP Vaccines Global Market Report 2024 – By Product type (DTaP, TD, Tdap), By Disease (Diphtheria, Pertussis, Tetanus), By End-User (Hospitals, Clinics, Vaccination Centers) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Pharmaceutical Drugs And Biologics Logistics Market 2021 - By Type Of Service (Cold Chain Logistics, Non-Cold Chain Logistics), By Mode Of Transport (Air Transportation, Ocean Transportation, Land Transportation), By Pharmaceutical Type (Pharmaceutical Drugs, Biologics), By Therapeutic Area (Metabolic Disorders Drugs, Anti-Infective Drugs, Central Nervous System Drugs, Respiratory Diseases Drugs, Cardiovascular Drugs, Musculoskeletal Disorders Drugs, Oncology Drugs, Hematology Drugs, Monoclonal Antibodies (MAbS), Genito-Urinary Drugs, Gastrointestinal Drugs, Therapeutic Proteins, Dermatology Drugs, Vaccines, Ophthalmology Drugs), And By Region, Opportunities And Strategies - Global Forecast To 2030

    View Report